| Literature DB >> 33804600 |
Elizabeth Torres-Arce1,2, Barbara Vizmanos1, Nancy Babio3,4,5, Fabiola Márquez-Sandoval1, Albert Salas-Huetos2,5.
Abstract
Infertility affects about 15% of the population and male factors only are responsible for ~25-30% of cases of infertility. Currently, the etiology of suboptimal semen quality is poorly understood, and many environmental and genetic factors, including oxidative stress, have been implicated. Oxidative stress is an imbalance between the production of free radicals, or reactive oxygen species (ROS), and the capacity of the body to counteract their harmful effects through neutralization by antioxidants. The purpose of this review, by employing the joint expertise of international researchers specialized in nutrition and male fertility areas, is to update the knowledge about the reproductive consequences of excessive ROS concentrations and oxidative stress on the semen quality and Assisted Reproduction Techniques (ART) clinical outcomes, to discuss the role of antioxidants in fertility outcomes, and finally to discuss why foods and dietary patterns are more innocuous long term solution for ameliorating oxidative stress and therefore semen quality results and ART fertility outcomes. Since this is a narrative review and not a systematic/meta-analysis, the summarized information in the present study should be considered cautiously.Entities:
Keywords: DNA fragmentation; antioxidant paradox; antioxidants; dietary patterns; foods; male fertility; nutrients; reactive oxygen species; semen quality; supplements
Year: 2021 PMID: 33804600 PMCID: PMC8003818 DOI: 10.3390/biology10030241
Source DB: PubMed Journal: Biology (Basel) ISSN: 2079-7737
Figure 1Flowchart of the generation of reactive oxygen species (ROS) during cellular respiration driven by the electron transport chain (ETC) in the mitochondria. Complex I, II, III, and IV constitute the ETC, and ATP synthase completes the oxidative phosphorylation. Fenton reaction constitutes the donation of an electron to transform H2O2 to two molecules of hydroxyl radicals. Abbreviations: ADP: Adenosine diphosphate. ATP: Adenosine triphosphate. CoQ: Coenzyme Q, ubiquinone. Cyt-C: cytochrome complex. FAD: FADH2 reduced form. FADH2: Flavin adenine dinucleotide. Fe2+: Ferrous ion. Fe3+: Ferric ion. H: Hydrogen. I.M.M.: Internal mitochondrial membrane. NAD: NADH reduced form. NADH: Nicotinamide adenine dinucleotide. O2: Oxygen. O2−: superoxide. SOD2: Superoxide dismutase 2 (mitochondrial variety).
Antioxidants related to male fertility by biological nature.
| 4.1 Physiological enzymatic factors | Superoxide Dismutase (SOD) | |
| 4.2 Non-enzymatic factors | Q-10 coenzyme (CoQ10) | |
| 4.3 Micronutrients | 4.3.1 Vitamins | Vitamin C |
| 4.3.2 Minerals | Zinc | |
| 4.4 Others | N-acetyl-cysteine (NAC) | |
Main positive associations or effects of single antioxidants related to sperm quality/male fertility by biological nature.
| Antioxidant & Doses | Article | Specie | Level of Evidence | Dose & Duration | Main Conclusions | Gaps in the Evidence |
|---|---|---|---|---|---|---|
| CoQ10 [ | [ | Human | Review and Meta-analysis | N/A | CoQ10 supplementation improved sperm motility and concentration. | RCTs with larger sample size, DNA fragmentation consequences, and ART outcomes |
| [ | Human | Review and Meta-analysis | N/A | CoQ10 is positively associated with sperm motility. | ||
| [ | Human | RCT | 200 mg/day for 24 weeks | CoQ10 supplementation improved sperm motility. | ||
| [ | Human | RCT | 200 mg/day for 12 weeks | CoQ10 supplementation improved TAC concentrations and decreased MDA levels. | ||
| [ | Human | Clinical trial (no control group) | 300 mg/day fro 26 weeks | CoQ10 supplementation improved sperm concentration and motility. | ||
| Carnitines [ | [ | Human | RCT | 25 mg/day for 3 months | Carnitines supplementation improved sperm count and motility. | RCTs with larger sample size, DNA fragmentation consequences, and ART outcomes |
| [ | Human | Observational | N/A | Higher seminal carnitines are positively associated with higher sperm counts, motility and morphology. | ||
| [ | Human | Observational | N/A | Higher seminal carnitines are positively associated with higher sperm count and motility. | ||
| Lycopene [ | [ | Human | Clinical trial (no control group) | 10 mg/twice a day for 3 months | Lycopene supplementation increased seminal Omega3. | RCTs with larger sample size, DNA fragmentation consequences, and ART outcomes |
| [ | Human | RCT | 25 mg/day for 12 weeks | Lycopene supplementation improved sperm count, concentration, motility; and higher TAC. | ||
| [ | Human | RCT | 10 mg/twice a day for 12 weeks | Lycopene supplementation decreases seminal oxidative stress. | ||
| Vitamin C [ | [ | Human | Review | N/A | Vitamin C is linked to decrease in agglutination and DNA damage parameters. | Higher grade evidence, such as a meta-analysis, RCTs with larger sample size, DNA fragmentation consequences, and ART outcomes |
| [ | Human | RCT | 1.0 g/day for 60 days | Vitamin C supplementation improved semen agglutination and increased viability. | ||
| [ | Human | RCT | 1000 mg of vitamin C were given every other day for 6 months | Vitamin C supplementation improved sperm concentration and motility. | ||
| [ | Human | Observational | N/A | Vitamin C intake levels is positively associated with higher fertilization rates | ||
| Vitamin E [ | [ | Human and others | Review | N/A | Vitamin E in humans plays a crucial role in the modulation of telomerase activity. | Higher grade evidence, such as a meta-analysis, RCTs with larger sample size, DNA fragmentation consequences, and ART outcomes |
| [ | Albino Wistar Rats | RCT | 100 mg/kg /day | Vitamin E supplementation improved sperm motility in nicotine exposed, stress induced rats and rats exposed to both nicotine and stress. | ||
| [ | Albino Wistar Rats | RCT | 500 mg/kg, 3 times a week for 2 weeks | Histological damage to the testes caused by aluminum was diminished by vitamin E supplementation. | ||
| [ | Human | Clinical trial (no control group) | 200mg/day for 3 months | Vitamin E supplementation decreased MDA levels and increased fertilization rates. | ||
| [ | Human | RCT | 600 mg/d for 3 months | Vitamin E supplementation improved sperm cells morphology in-vitro, during the zona binding assay. | ||
| [ | Human | RCT | 100mg/3 times a day for 6 months or until pregnancy | Vitamin E supplementation decrease MDA levels and improved sperm motility. | ||
| Vitamin B9 [ | [ | Human | RCT | 5mg/day for 26 weeks | Vitamin B9 and zinc supplementation improved sperm count. | RCTs with larger sample size, DNA fragmentation consequences, and ART outcomes |
| [ | Human | Systematic Review and Meta-analysis | N/A | Vitamin B9 is positively associated with higher sperm concentration in infertile men. | ||
| [ | Human | Systematic Review and Meta-analysis | N/A | Vitamin B9 is positively associated with sperm morphology. | ||
| Zinc [ | [ | Human | Systematic Review and Meta-analysis | N/A | Zinc supplementation was positively associated with improvements in sperm chromatin integrity index, sperm concentration, motility, membrane integrity, fertilizing capacity, conception, and pregnancy. | Comparative studies determining the best dosage-effect in zinc supplementation. |
| [ | Human | Systematic Review | N/A | Zinc concentration is significantly higher in fertile men. | ||
| [ | Human | RCT | 250 mg/twice a day for 3 months | Zinc supplementation improved sperm count, motility, fertilizing and reduction in the incidence of antisperm antibodies. | ||
| [ | Human | RCT | 220 mg/day for 16 weeks | Zinc supplementation improved sperm chromatin integrity. | ||
| [ | Human | Systematic Review and Meta-analysis | N/A | Higher mean seminal Zinc levels are found in fertile men. Zinc supplementation is positively associated with semen volume, sperm motility and the percentage of normal sperm morphology. | ||
| [ | Human | Review | N/A | Zinc is positively associated with lower ROS production in smokers. | ||
| [ | Human | Observational Study | N/A | Higher seminal Zinc is positively associated with sperm count and morphology. | ||
| Selenium [ | [ | Human | RCT | 200 μg /day for 3 months | Selenium supplementation improved TAC and sperm motility. | Higher grade evidence, such as a meta-analysis, RCTs with larger sample size, DNA fragmentation consequences, and ART outcomes |
| [ | Human | RCT | 200 μg /day for 26 weeks | Selenium supplementation improved sperm concentration, motility, and morphology. | ||
| [ | Human | RCT | 100 mg/day for 3 months | Selenium supplementation improved sperm count and motility. | ||
| [ | Human | Observational | N/A | Higher seminal selenium values are positively associated with sperm count and motility. | ||
| [ | Human | Observational | N/A | Higher selenium intake is positively associated with sperm motility. | ||
| [ | Human | N/A | Seminal selenium is positively associated with sperm concentration and total sperm count. | |||
| [ | Human | Observational | N/A | Seminal selenium is positively associated with pregnancy and live birth. | ||
| NAC [ | [ | Human | Systematic Review and Meta-analysis | 600 mg/day for 6 months | NAC supplementation improved semen volume, sperm count and concentration, sperm motility, and morphology. | RCTs with larger sample size, DNA fragmentation consequences, and ART outcomes |
| [ | Albino Wistar Rat | RCT | Single dose of 20 mg/kg NAC intravenous | NAC administration improved MDA levels in a postreperfusion testicular injury. | ||
| [ | Human | Observational | N/A | NAC incubation reduces the apoptotic rate by 68% compared to controls with no NAC. | ||
| [ | Human | RCT | 600 mg/day for 3 months | NAC supplementation improved sperm volume, motility, and viscosity, as well as TAC. | ||
| [ | Human | RCT | 600 mg/day for 3 months | NAC supplementation improved sperm morphology, DNA fragmentation and protamine deficiency. TAC significantly increased and MDA levels decreased under this supplementation. | ||
| [ | Human | Observational | N/A | NAC incubation of sperm cells is positively associated with a decrease in ROS production. | ||
| [ | Human | RCT | 600 mg/day for 3 months | NAC supplementation affects NRF2 expression and therefore decrease in ROS. | ||
| [ | Human & Albino Wistar Rat | Systematic Review | N/A | NAC supplementation improved DNA fragmentation indices and ROS production. | ||
| [ | Goat (Capra hircus) | Observational | N/A | Sperm NAC incubation resulted in positively associated with a decrease of testicular cell apoptosis. | ||
| Melatonin | [ | Human | Observational | N/A | Sperm melatonin incubation is positively associated with less DNA damage, and MDA levels; and higher sperm viability. | RCTs with larger sample size, DNA fragmentation consequences, and ART outcomes, and studies without involving alterations in the circadian rhythm. |
| [ | Human | Observational | N/A | Mean seminal plasma melatonin levels are higher in fertile men, with higher sperm motility than infertile individuals. | ||
| [ | Human | Observational | N/A | Lower melatonin serum and seminal levels are present in men with oligoasthenoteratozoospermia compared to controls. Melatonin is positively associated with sperm motility. | ||
| [ | Human | Observational | N/A | Sperm melatonin incubation is positively associated with higher sperm cell viability. | ||
| [ | Human | Observational | N/A | Sperm melatonin incubation is positively associated with sperm motility and less static cells. | ||
| Alpha lipoic acid [ | [ | Human | RCT | 600 mg/day for 80 days | ALA improved sperm motility and progressive motility, and less DNA damage. | Higher grade evidence, such as a meta-analysis, RCTs with larger sample size, DNA fragmentation consequences, and ART outcomes |
| [ | Human, rats and boars | Systematic Review | NA | ALA incubation in boars is associated with higher sperm motility, less DNA damage. ALA supplementation in humans is associated with a higher TAC. ALA supplementation in diabetic rats caused increased sperm concentration and motility compared to not supplemented diabetic rats. | ||
| [ | Human | RCT | 600 mg/day for 12 weeks | ALA supplementation improved sperm count and concentration, higher TAC and lower MDA. | ||
| [ | Human | Observational | N/A | Sperm incubation with 0.2 mM of ALA increased sperm viability and decreased DNA damage. | ||
| [ | Human | Observational | N/A | Sperm incubation with 0.2 and 0.5 mM of ALA improved the motility, viability and morphology of frozen-thawed specimens. | ||
| Omega3 [ | [ | Human | Systematic Review | N/A | Omega-3 has a positive effect on semen quality markers in semen of infertile men. | Higher grade evidence, such as a meta-analysis, RCTs with larger sample size, DNA fragmentation consequences, and ART outcomes |
| [ | Human | RCT | 1.8 g/day for 32 weeks | Omega3 supplements improved sperm concentration, motility and normal morphology. | ||
| [ | Human | Observational | N/A | Omega3 (fish oil) supplements are positively associated with higher semen volume, total sperm count, testis size. | ||
| [ | Human | Systematic Review and Meta-analysis | NA | Omega3 supplements improved sperm concentration and sperm motility. | ||
| [ | Human | RCT | 500 mg/ 3 times a day for 10 weeks | Omega3 supplements improved TAC concentrations and reduced DNA fragmentation |
Abbreviations: DNA: Deoxyribonucleic acid. DHA: Docosahexanoic acid. MDA: Malondialdehyde. mcg: micrograms. MDD: Maximum daily Dose. mg: milligrams. N/A: Not applicable. RCT: Randomized Controlled Trial. RDD: Recommended daily dose. ROS: Reactive Oxygen species. RSD: Recommended supplementation dosage. TAC: Total antioxidant capacity. 5. The synergistic effect of concomitant antioxidant supplementation
Figure 2Location of SOD group in relation to cell and mitochondria. SOD1 (Cytosolic SOD or CuZn-SOD). SOD2 (Mitochondrial SOD or Mn-SOD). SOD3 (tetrameric extracellular SOD or EC-SOD).